| pubmed-article:9437483 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:9437483 | lifeskim:mentions | umls-concept:C0278627 | lld:lifeskim |
| pubmed-article:9437483 | lifeskim:mentions | umls-concept:C0205721 | lld:lifeskim |
| pubmed-article:9437483 | lifeskim:mentions | umls-concept:C0021708 | lld:lifeskim |
| pubmed-article:9437483 | pubmed:issue | 6 | lld:pubmed |
| pubmed-article:9437483 | pubmed:dateCreated | 1998-2-11 | lld:pubmed |
| pubmed-article:9437483 | pubmed:abstractText | Treatment of cancer has contributed to a growing number of immunocompromised patients with life-threatening nosocomial infections (NI). High mortality with considerable cost is observed when they are admitted to the intensive care unit (ICU). Few studies on infection control and surveillance have been undertaken in this population group. | lld:pubmed |
| pubmed-article:9437483 | pubmed:language | eng | lld:pubmed |
| pubmed-article:9437483 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9437483 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:9437483 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:9437483 | pubmed:month | Dec | lld:pubmed |
| pubmed-article:9437483 | pubmed:issn | 0196-6553 | lld:pubmed |
| pubmed-article:9437483 | pubmed:author | pubmed-author:MartinsC ACA | lld:pubmed |
| pubmed-article:9437483 | pubmed:author | pubmed-author:VelascoEE | lld:pubmed |
| pubmed-article:9437483 | pubmed:author | pubmed-author:DiasL MLM | lld:pubmed |
| pubmed-article:9437483 | pubmed:author | pubmed-author:GonçalvesV... | lld:pubmed |
| pubmed-article:9437483 | pubmed:author | pubmed-author:ThulerL CLC | lld:pubmed |
| pubmed-article:9437483 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:9437483 | pubmed:volume | 25 | lld:pubmed |
| pubmed-article:9437483 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:9437483 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:9437483 | pubmed:pagination | 458-62 | lld:pubmed |
| pubmed-article:9437483 | pubmed:dateRevised | 2009-8-14 | lld:pubmed |
| pubmed-article:9437483 | pubmed:meshHeading | pubmed-meshheading:9437483-... | lld:pubmed |
| pubmed-article:9437483 | pubmed:meshHeading | pubmed-meshheading:9437483-... | lld:pubmed |
| pubmed-article:9437483 | pubmed:meshHeading | pubmed-meshheading:9437483-... | lld:pubmed |
| pubmed-article:9437483 | pubmed:meshHeading | pubmed-meshheading:9437483-... | lld:pubmed |
| pubmed-article:9437483 | pubmed:meshHeading | pubmed-meshheading:9437483-... | lld:pubmed |
| pubmed-article:9437483 | pubmed:meshHeading | pubmed-meshheading:9437483-... | lld:pubmed |
| pubmed-article:9437483 | pubmed:meshHeading | pubmed-meshheading:9437483-... | lld:pubmed |
| pubmed-article:9437483 | pubmed:meshHeading | pubmed-meshheading:9437483-... | lld:pubmed |
| pubmed-article:9437483 | pubmed:meshHeading | pubmed-meshheading:9437483-... | lld:pubmed |
| pubmed-article:9437483 | pubmed:meshHeading | pubmed-meshheading:9437483-... | lld:pubmed |
| pubmed-article:9437483 | pubmed:year | 1997 | lld:pubmed |
| pubmed-article:9437483 | pubmed:articleTitle | Nosocomial infections in an oncology intensive care unit. | lld:pubmed |
| pubmed-article:9437483 | pubmed:affiliation | Infectious Disease Service and Hospital Infection Control Committee, National Cancer Institute, Rio de Janeiro, Brazil. | lld:pubmed |
| pubmed-article:9437483 | pubmed:publicationType | Journal Article | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9437483 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9437483 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9437483 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9437483 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9437483 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9437483 | lld:pubmed |
